CR GROUP L.P. sold 50.0% of their position (5.08M shares) of T2 BIOSYSTEMS, INC. on the open market
Open‑market sale worth $1.31M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 4 sales
Filed: 9/26/2023ACC: 0001209191-23-050592
-5.08M
Net shares
Net seller
$1.31M
Total sold
4
Open market trades
0B · 4S
4
Total transactions
5.08M disposed
Non-Derivative Transactions4
Common Stock
Indirect
Shares
−2.03M
Price / share
$0.26
Trade value
$525.70K
% of position
21.3%
9/22/2023
9.54M→7.51M
Common Stock
Indirect
Shares
−1.26M
Price / share
$0.26
Trade value
$327.36K
% of position
21.3%
9/22/2023
5.94M→4.68M
Common Stock
Indirect
Shares
−406.26K
Price / share
$0.26
Trade value
$105.14K
% of position
21.3%
9/22/2023
1.91M→1.50M
Common Stock
Indirect
Shares
−1.38M
Price / share
$0.26
Trade value
$356.33K
% of position
21.3%
9/22/2023
6.47M→5.09M
Total
Net shares
−5.08M
Net value
-$1.31M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 9/22/2023 | S · Sale | −2.03M | $0.26 | $525.70K | 21.3% | 9.54M | 7.51M |
| Common Stock Indirect | 9/22/2023 | S · Sale | −1.26M | $0.26 | $327.36K | 21.3% | 5.94M | 4.68M |
| Common Stock Indirect | 9/22/2023 | S · Sale | −406.26K | $0.26 | $105.14K | 21.3% | 1.91M | 1.50M |
| Common Stock Indirect | 9/22/2023 | S · Sale | −1.38M | $0.26 | $356.33K | 21.3% | 6.47M | 5.09M |
| Total | −5.08M | -$1.31M | ||||||
Derivative Transactions0
No derivative transactions reported